Lantern Pharma Inc. (LTRN) Social Stream
LANTERN PHARMA INC (LTRN) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering LTRN.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-02-09 | 2 | $34 | $29 | $31 | $4.39 | 606.15% |
| 2022-03-14 | 2 | $36 | $26 | $31 | $4.39 | 606.15% |
| 2022-03-22 | 1 | $29.001 | $26 | $27.5 | $4.39 | 526.42% |
| 2022-08-09 | 1 | $26 | $26 | $26 | $4.39 | 492.26% |
| 2023-05-10 | 1 | $26 | $11 | $18.5 | $4.39 | 321.41% |
| 2023-11-09 | 2 | $26 | $11 | $18.5 | $4.39 | 321.41% |
The Trend in the Analyst Price Target
Over the past 20 months, LTRN's average price target has gone down $1.5.
LTRN reports an average of 365.67% for its upside potential over the past 40 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-05-10 | 1 | 26 | 11 | 18.5 | 5.57 | 232.14% |
| 2023-05-10 | 2 | 26 | 11 | 18.5 | 5.57 | 232.14% |
| 2023-11-09 | 2 | 26 | 11 | 18.5 | 3.73 | 395.98% |
| 2023-11-09 | 1 | 26 | 11 | 18.5 | 3.73 | 395.98% |
| 2023-11-09 | 2 | 26 | 26 | 26.0 | 3.73 | 597.05% |
LTRN Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2 | 1 | 0 | 1 | 0 | 0 | 2 |
The Trend in the Broker Recommendations
Over the past 26 weeks, LTRN's average broker recommendation rating worsened by 2.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for LTRN as an investment opportunity.
- To contextualize these metrics, consider that out of all US stocks, LANTERN PHARMA INC's number of analysts covering the stock is higher than 14.2% of them.
- In terms of how LANTERN PHARMA INC fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is higher than 753.46% of that group.
- LTRN has a higher average analyst price target than 685.68% of stocks in the micro market cap category.
- In the context of Healthcare stocks, LANTERN PHARMA INC's variance in analysts' estimates is lower than -100.75% of them.
In the Pharmaceutical Products industry, REVB, VIRI, and BPTS are the three stocks most similar to LANTERN PHARMA INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Is LTRN a Buy, Hold or Sell? See the POWR Ratings now!